Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Your second point implies they won't have to raise cash until 2Q19, which is not true. They raised cash now because if they didn't, from am audit standpoint, they would have to report they are a "Going Concern" so the $2 raise bought them another 3-4 month before they need to bring in more cash to have at least a years worth and doing another dilution at this stock price would be catastrophic to sharehdoler value even more than the last dilution.